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Identity 
Other names: C3G, DKFZp781P1719, GRF2 
HGNC (Hugo): RAPGEF1 
Location: 9q34.13 
Local order: c-Abl non-receptor tyrosine kinase, 
RapGEF1, sarcosine dehydrogenase, bromodomain 
containing 3, ADP-ribosylation factor 4 pseudogene. 
 
Human chromosome 9 map showing the position of C3G (RapGEF1). 
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The human RAPGEF1/C3G gene is comprised of 24 
exons, spanning 163 kb on chromosome 9q34.13. 
Transcription 
Expression is ubiquitous, with some tissues like the 
heart, uterus and skeletal muscle showing higher 
expression. 
Alternative spliced forms: Human RAPGEF1/C3G has 
two isoforms - isoform a and b which differ in the N-
terminal (3 aa of Isoform a replaced by 21 aa in 
isoform b). Isoform-a has 6085 bps of transcript length 
whereas isoform-b has 6256 bps of transcript length. 
An alternate isoform in rat has a 153bp insertion which 
is expressed only in testis and brain. 
A truncated isoform is expressed in CML cells (K562) 





This 140 kDa protein is a guanine nucleotide exchange 
factor for some members of Ras family GTPases.  
Size: isoform a: 1077 amino acids; isoform b: 1095 
amino acids. 
Domains: C-terminal catalytic domain: homologous to 
CDC25, exchange factor activity. 
Central protein interaction domain: contains poly-
proline tracts, with the ability to bind to SH3 domains 
of various proteins. 
N-terminal non-catalytic domain contains an E-
cadherin binding domain. 
Catalytic activity: Activates downstream GTPases like 
Ras family members Rap1, Rap2, R-Ras, TC21 and 
Rho family member TC-10. 
Expression 
Expression is ubiquitous. Higher levels of 
RAPGEF1/C3G are seen in differentiated human 
neuroblastoma cells compared to undifferentiated cells. 
Interacting partners: p130Cas, Crk, Crk-L, Grb2, 
Hck, PDGF, Cas-L, Shc, Rap1, c-Abl, PP2A and E-
cadherin. 
Tyrosine phosphorylation: phosphorylated 
predominantly at Y504; phosphoryaltion also at other 
tyrosine residues. Kinases known to phosphorylate 
RAPGEF1/C3G are Hck, Src, c-Abl and Fyn. Rat and 
mouse isoforms show changes in sequence surrounding 
Y504. 
Membrane anchoring: Constitutive association with 
Crk enables the complex to interact with phospho-
tyrosine motifs upon stimulation of growth factor 
receptors in the cell membrane. 
Actin cytoskeleton binding: Binds to actin 
cytoskeleton; phosphorylation at Y504 enhances F-
actin binding. 
Downstream effectors: Ras family members Rap1, 
Rap2, R-Ras, TC21, Rho family member TC-10. 
 
Schematic showing the domain organization of RAPGEF1/C3G protein. The C-terminal catalytic domain of C3G is homologous to 
CDC25 and is responsible for target G protein activation. The N-terminal region has a domain which interacts with E-cadherin. The 
central protein interaction domain (also known as Crk binding region, CBR) contains multiple proline-rich sequences that bind SH3 
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Localisation 
Cytosolic. 
Upon stimulation of growth factor receptors can be 
recruited to plasma membrane. 
Upon phosphorylation by Src family kinases localizes 
to Golgi and sub-cortical cytoskeleton. 
Also localizes to tips of filopodia and membranous 
ruffles. 
 
Cellular functions involving C3G mediated signalling. C3G 
is involved in signalling pathways triggered by upstream 
activators like integrin binding, B cell receptor, T cell receptor, 
insulin, EGF, NGF, TXT: interferon-gamma, Hepatocyte growth 
factor, growth hormone, Reelin, mechanical force, Nectin, 
cadherin engagement, Erythropoietin and interleukin-3. 
Through its catalytic function it activates downstream G proteins 
by switching them from an inactive GDP bound state to an 
active GTP bound form. It targets the Ras family members 
Rap1, Rap2, R-Ras, and Rho family member TC-10, leading to 
activation of MAP kinases that play a role in cell proliferation 
and integrin-mediated signaling. C3G also has functions which 
are independent of its catalytic domain, where it behaves like 
an adaptor protein. Such functions include apoptosis and 
suppression of transformation. 
Function 
- Suppression of transformation: In cells expressing 
various oncogenes C3G shows transformation-
suppression activity independent of its catalytic 
domain. This function is mediated by inhibition of 
ERK phosphorylation and cyclin A expression. 
- Cell survival and apoptosis: C3G expression 
protects against serum starvation induced cell death in 
neuroblastoma cells through induction of p21. Co-
expression of Hck with C3G induced high level of 
apoptosis in many cell lines. C3G is phosphorylated at 
Y504 in cells undergoing apoptosis as a consequence of 
c-Abl expression. C3G is required for c-Abl induced 
apoptosis. 
Upon serum deprivation, C3G induces survival in 
MEFs through inhibition of p38alpha MAPK activity, 
which mediates apoptosis. In response to oxidative 
stress, C3G behaves as a pro-apoptotic molecule, as its 
knockdown or knockout enhances survival through up-
regulation of p38alpha activity, which plays an anti-
apoptotic role under these conditions. 
- Cell cycle arrest: C3G expression induced the cell 
cycle inhibitor p21 in human neuroblastoma cells. 
- Filopodia formation: C3G is required for c-Abl-
induced filopodia during cell spreading on fibronectin. 
C3G expression induces actin cytoskeletal 
reorganization and promotes filopodia formation 
independent of its catalytic activity. 
- Neuronal differentiation: C3G is induced during 
neuronal differentiation and is required for 
differentiation of human neuroblastoma cells. 
- Cell Proliferation: Expression of membrane targeted 
C3G in Drosophila leads to cell fate changes and 
overproliferation during development, mediated by the 
RAS-MAPK pathway and RAP1. 
- Muscle integrity: C3G is an accessory component of 
the Drosophila musculature, essential for the proper 
localization of integrins at muscle-muscle and muscle-
epidermis attachment sites and important for 
maintaining muscle integrity during larval stages. 
Knockout phenotype: 
- Knockout mice show embryonic lethality with C3G-/- 
homozygous animals dying before embryonic day 7.5. 
Fibroblasts from knockout animals show impaired cell 
adhesion, delayed cell spreading and accelerated cell 
migration. 
- Animals expressing hypomorphic allele of C3G show 
overproliferation of the cortical neuroepithelium, 
cortical neuron migration defects, and defects in blood 
vessel maturation. 
Homology 
C3G shares homology only in catalytic domain with 
other Ras family GTPases. It lacks multiple modular 








p87 isoform of C3G lacking N-terminal 305 residues 
expressed in CML cell lines and Ph+ patients has been 
suggested to play a role in pathogenesis of CML. 
Decreased C3G expression due to hypermethylation 
was seen in cervical squamous cell carcinomas.  
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Amplification of C3G is associated with primary non-
small cell lung carcinomas, which also show higher 
levels of protein expression in cancerous cells.  
SNPs in the C3G gene have shown association with 
Type 2 diabetes in Korean and Finnish populations. 
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